Treatment-Resistant Depression in a Real-World Setting: First Interim Analysis of Characteristics, Healthcare Resource Use, and Utility Values of the FondaMental Cohort.
Fiche publication
Date publication
décembre 2020
Journal
Brain sciences
Auteurs
Membres identifiés du Cancéropôle Est :
Pr HAFFEN Emmanuel
Tous les auteurs :
Yrondi A, Bennabi D, Haffen E, Quelard D, Samalin L, Maruani J, Allauze E, Pierre D, Bougerol T, Camus V, D'Amato T, Doumy O, Holtzmann J, Lançon C, Moliere F, Moirand R, Nieto I, Richieri RM, Horn M, Schmitt L, Stephan F, Genty JB, Vaiva G, Walter M, Courtet P, Leboyer M, Llorca PM, Marguet S, Dennis N, Schaetz D, El-Hage W, Aouizerate B
Lien Pubmed
Résumé
Major depressive disorder (MDD) is among the most common psychiatric disorders. One-third of patients are usually unresponsive to several lines of treatment. This study aimed to describe the FondaMental French cohort of patients with treatment-resistant depression (TRD) and to estimate utility and healthcare resource use outcomes.
Mots clés
healthcare resource use, real-world, treatment-resistant depression, utility
Référence
Brain Sci. 2020 Dec 10;10(12):